Science Explorer Back to mapMap
Discussion
Researcher · Emma Kinderziekenhuis · Netherlands

Huib N. Caron

Huib N. Caron publishes mostly in Neurology, Molecular Biology and Pediatrics, Perinatology and Child Health, on topics such as Neuroblastoma Research and Treatments, Childhood Cancer Survivors' Quality of Life and Cancer, Hypoxia, and Metabolism.

OpenAlex
World rank
#119,748
of 7,710,434 ranked researchers
Rank in Netherlands
#2,897
of 107,149
Works
281
Citations
20k
Citations per work
72.0
h-index
65
i10-index 150Top 1.4% in Neurology (Medicine)
Huib N. Caron

What does Huib N. Caron research?

Huib N. Caron's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (26%).

Health Sciences: 118 works · 42.1% of their workMedicine: 118 works · 42.1% of their workNeurology: 52 works · 18.5% of their workPediatrics, Perinatology and Child Health: 32 works · 11.4% of their workPublic Health, Environmental and Occupational Health: 19 works · 6.7% of their workOncology: 15 works · 5.5% of their workEverything else: 90 works · 32.2% of their workLife Sciences: 72 works · 25.7% of their workBiochemistry, Genetics and Molecular Biology: 72 works · 25.7% of their workMolecular Biology: 47 works · 16.9% of their workCancer Research: 25 works · 8.8% of their workTHEIR WORKHuib N. Caron281works
Life Sciences26%Health Sciences42%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine11842.1%
  2. Everything else9032.2%
    1. Biochemistry, Genetics and Molecular Biology7225.7%
  1. 1Neurology18% of their works
  2. 2Molecular Biology17% of their works
  3. 3Pediatrics, Perinatology and Child Health11% of their works
  4. 4Cancer Research9% of their works
  5. 5Public Health, Environmental and Occupational Health7% of their works
  6. 6Oncology6% of their works

Research topics

Which keywords describe Huib N. Caron's research?

The keywords of their largest research topics: Immunotherapy, ALK, Neuroblastoma, Childhood Cancer Survivor Study, Pediatric Quality of Life Inventory, HIF-1, Warburg Effect and Chemotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Immunotherapy1162 topics
  2. ALK1001 topic
  3. Neuroblastoma1001 topic
  4. Childhood Cancer Survivor Study531 topic
  5. Pediatric Quality of Life Inventory531 topic
  6. HIF-1481 topic
  7. Warburg Effect481 topic
  8. Chemotherapy342 topics
  9. Acute Lymphoblastic Leukemia271 topic
  10. Childhood Cancer271 topic
  11. Anthracyclines201 topic
  12. Doxorubicin201 topic
  13. Glioblastoma161 topic
  14. Temozolomide161 topic
  15. DNA141 topic
  16. Topoisomerases141 topic
  17. Apoptosis111 topic
  18. Cell Death111 topic

Where does Huib N. Caron work?

Huib N. Caron's main affiliation in the publication record is Emma Kinderziekenhuis, Netherlands.

How many publications and citations does Huib N. Caron have?

OpenAlex counts 281 works and 20,222 citations for Huib N. Caron, an h-index of 65, ranking #119,748 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Huib N. Caron. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.